• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to 3-METHOXY-5-NITRO-1H-INDAZOLE (CAS No. 1118574-49-4)

3-METHOXY-5-NITRO-1H-INDAZOLE, identified by the Chemical Abstracts Service Number (CAS No.) 1118574-49-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indazole family, characterized by a fused benzene and pyrrole ring system, with functional groups that contribute to its unique chemical properties and potential biological activities. The presence of both a methoxy group and a nitro group on the indazole core imparts distinct reactivity and interaction profiles, making it a valuable scaffold for the development of novel therapeutic agents.

The structural features of 3-METHOXY-5-NITRO-1H-INDAZOLE make it a promising candidate for further exploration in drug discovery. The methoxy group, attached at the 3-position of the indazole ring, can influence electronic distribution and hydrogen bonding capabilities, while the nitro group at the 5-position introduces electrophilic reactivity and potential for redox transformations. These modifications enhance the compound's versatility in chemical synthesis and biological evaluation.

In recent years, there has been growing interest in indazole derivatives due to their demonstrated pharmacological properties. Studies have highlighted the potential of indazole-based compounds in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer applications. The specific arrangement of functional groups in 3-METHOXY-5-NITRO-1H-INDAZOLE may contribute to its efficacy in modulating biological pathways associated with these diseases.

One of the most compelling aspects of 3-METHOXY-5-NITRO-1H-INDAZOLE is its utility as a building block in medicinal chemistry. Researchers have leveraged its scaffold to design and synthesize analogs with enhanced or modified biological activities. For instance, modifications at the 3-position or 5-position can fine-tune interactions with target enzymes or receptors, leading to improved drug-like properties such as solubility, bioavailability, and selectivity.

Recent advancements in computational chemistry have further accelerated the exploration of 3-METHOXY-5-NITRO-1H-INDAZOLE and its derivatives. Molecular modeling techniques allow researchers to predict binding affinities, optimize molecular structures, and identify potential lead compounds efficiently. These computational approaches complement traditional experimental methods, enabling faster screening of candidate molecules for therapeutic development.

The pharmacological profile of 3-METHOXY-5-NITRO-1H-INDAZOLE has been investigated in several preclinical studies. Initial findings suggest that this compound exhibits inhibitory effects on certain enzymes and receptors relevant to inflammatory diseases. The nitro group's ability to engage in redox reactions may play a crucial role in modulating inflammatory pathways, while the methoxy group could contribute to stabilizing protein-ligand interactions.

In addition to its potential therapeutic applications, 3-METHOXY-5-NITRO-1H-INDAZOLE has been explored for its role in chemical synthesis. Its reactivity allows for diverse functionalization strategies, making it a valuable intermediate in organic synthesis. Researchers have utilized this compound to develop novel synthetic routes to more complex indazole derivatives, expanding the arsenal of molecules available for drug discovery efforts.

The future prospects for 3-METHOXY-5-NITRO-1H-INDAZOLE are promising, with ongoing research aimed at elucidating its mechanism of action and optimizing its pharmacological properties. Collaborative efforts between academic institutions and pharmaceutical companies are likely to drive further innovation in this area. As our understanding of biological pathways continues to evolve, compounds like 3-METHOXY-5-NITRO-1H-INDAZOLE may emerge as key players in next-generation therapeutics.

From a regulatory perspective, ensuring the safety and efficacy of new drug candidates is paramount. While 3-METHOXY-5-NITRO-1H-INDAZOLE itself is not classified as a high-risk compound, rigorous testing is essential before any clinical application can be considered. Preclinical studies must thoroughly evaluate toxicity profiles, pharmacokinetics, and potential side effects to ensure patient safety.

The synthesis of 3-METHOXY-5-NITRO-1H-INDAZOLE involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to improve yield and purity, ensuring that researchers working with this compound have access to high-quality material for their studies.

In conclusion,3-METHOXY-5-NITRO-1H IND AZOLE (CAS No: 1118574 49 4) represents a significant advancement in pharmaceutical chemistry with potential applications across multiple therapeutic domains. Its unique structural features and reactivity make it an attractive scaffold for drug development, offering opportunities for innovation through both experimental and computational approaches.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)